Journal article Open Access
Remya Bhaskaran S, G. Saranya, P.Vaishnavi Reddy, Dr. Ritty Sara Cherian, Dr. B.A Vishwanath
Elevated blood pressure is the major cause of increase in death rate in patients with end stage renal disease. The management of hypertension in end stage renal disease is a major challenge, inorder to reduce the risk of morbidity and mortality. Antihypertensive agents plays an important role in ESRD patients by reducing the risk factors. In India the incidence rate of CKD is increasing from 2006, where as the age adjusted incidence rate of ESRD is 229/million population. A recent study from Western India demonstrated that the occurrence of hypertension is 85%-95% in ESRD patients. This study aims to evaluate the most appropriate non pharmacological and pharmacological treatments in the control of elevated blood pressure in patients with end stage renal disease. Our study shows that Clonidine and Nifedipine was the antihypertensive drug preferred in majority of the ESRD patients.The result of our study suggest that the control of blood pressure is essential, which can be achieved through strict medication adherence and lifestyle modification in the end stage renal disease patients.